Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2025-12-24 @ 2:00 PM
NCT ID: NCT00785395
Eligibility Criteria: Inclusion Criteria: 1. Non-emergent cesarean delivery with planned spinal anesthesia (i.e. elective planned cesarean delivery for malposition, patient choice, cervical pelvic disproportion, previous cesarean delivery and other diagnosis that require a predetermined cesarean delivery) 2. American Society of Anesthesia physical status class I \& II (ASA I - Healthy, ASA II - mild and controlled systemic disease, eg. controlled essential hypertension) 3. Age ≥ 18 years 4. Term gestational age (≥ 37 weeks) 5. English-speaking Exclusion Criteria: 1. Morbid Obesity (Body Mass Index ≥ 45 kg/m2) (Morbidly obese parturients require a dose of local anesthetic less than the standardized dose in this study and the blood pressure cuff occasionally needs to be replaced by an intraarterial catheter due to limitations in size) 2. Laboring women 3. Urgent or emergency cesarean delivery 4. Severe hypertensive disease of pregnancy defined as systolic blood pressure (SBP) \> 160mmHg, diastolic blood pressure (DBP) \> 110mmHg and/or requiring antihypertensive treatment or associated with significant proteinuria 5. Severe maternal cardiac disease 6. Subjects predisposed to uterine atony and postpartum hemorrhage (i.e. placenta previa, multiple gestation, macrosomia, polyhydramnios, uterine abnormalities, or bleeding diathesis, \> 2 previous CD) 7. Fetal anomalies /Intrauterine Fetal Demise 8. Failed spinal anesthesia 9. Patient enrollment in another study involving a study medication within 30 days of CD 10. Any other physical or psychiatric condition which may impair their ability to cooperate with study data collection
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Study: NCT00785395
Study Brief:
Protocol Section: NCT00785395